LET'S REPAIR AND MODERNIZE THE SHARPE RATIO
- Average (arithmetic mean) of returns can be highly misleading.
- Variance and standard deviation are not identities of, nor analogies for, risk.
- Placing two measurements into a ratio can be distortive. Changes in the numerator (mean returns) move the ratio linearly, while changes in the denominator (standard deviation of returns) move the ratio hyperbolically. This leads to a sometimes unhelpful bias to funds with lower returns and lower variance. A fund with no variability of returns, has an infinite Sharpe Ratio, regardless of return. That is not helpful to the analysis.
- A comparison to an index may yield misleading results, as any negative correlation, which may be desirable for the investor, increases the variance, thus lowering the Sharpe Ratio. A comparison to a risk-free investment does not have this limitation, as such typically has no variance.
Let's dive in.
Let's walk through the derivation of the Sharpe Ratio. (Don't be discouraged if you don't understand the mathematics; We'll try to explain as we go along.) The ex-post Sharpe Ratio measures how high the returns were, versus how varied those returns were. More specifically, it is the ratio of the differential returns (difference between the returns of the investment and a benchmark investment) versus the historic variability (as standard deviation) of those returns. Some select a "risk-free" investment (treasury bond) as the benchmark, while others choose an index like the S&P 500. Because an index of securities has its own variability, which, in calculating the difference of returns, are indistinguishable from the variability of the fund, we choose to use the risk free rate in our study. Here is the Sharpe Ratio derivation [from Sharpe, 1994], then explanation below:
$R_{Ft}$
$R_{Bt}$
- the return of the investment (fund) in period t, minus
- the return of the benchmark in period t.
- the average value (arithmetic mean) of the above differential returns
(Mean is the "first moment" of statistical analysis. It is the "average" of the values.)
- standard deviation of differential returns
Why did we go through this exercise? We wanted to show you the components of the Sharpe Ratio, and how it is constructed, so we can then demonstrate our methods for improving it. To calculate the Sharpe Ratio, one must first calculate the returns per sub-period of the investment, compare them to a benchmark during the same sub-period, and calculate the difference. Then, the average of the differences is divided by the standard deviation (variability, or noise) of those differences. For example, let's say one wanted to calculate the Sharpe Ratio for a fund over one year, and uses the monthly returns for the sub-periods. In a spreadsheet, one would put the monthly returns of the fund in one column, the monthly returns of the benchmark investment in another column, and calculate the difference between the two for a third column. Using this column of differences, one would find the average and the standard deviation, and calculate the ratio. It is far more simple than it appears in the mathematics above; Most spreadsheet programs will calculate the mean and standard deviation for you.
| Fund #1. | Periodic returns: 10%, 5%, -5%, -10%. | Average return: 0% |
| Fund #2. | Periodic returns: 90%, 50%, -50%, -90%. | Average return: 0% |
These two funds would be indistinguishable were one only to look at the average returns. However, the realized returns are quite different. At the end of these four periods, the total return of Fund #1 is -1.25% ((1.10 * 1.05 * 0.95 * 0.90) - 1), while the total return for Fund #2 is -85.75% ((1.90 * 1.50 * 0.50 * 0.10) - 1). In neither case does the average return reflect a losing investment, nor make any distinction between these two quite different funds. Simple arithmetic averages, when dealing with return percentages, can be wildly inaccurate.
Consider these funds:
Our solution to this problem is outlined below, but let's continue identifying issues that need to be addressed...
As an aside, an investor could choose two high-return, high-variability funds that are negatively correlated. That would have the benefit of adding return to the portfolio, while counterbalancing variability. Reliance on the Sharpe Ratio alone does not facilitate selection of such funds.
Consider these funds:
This serves as a nice segue into another issue, so let's get this out of the way:
Which of these funds would be most favorable going forward? Which is most risky? Many investors believe that, during short sample periods, returns are random, with prices moving in Brownian motion fashion. Thus, each of the returns shown would be equally likely, alternative histories, with the same probability of occurrence. As such, they would be indistinguishable from one another, as far as probability of returns going forward, and each would have the same risk. But, is that truly the case?
Over time, prices and returns are not random; They are intentional. Countless man-hours are invested daily in efforts to increase capital, asset, and security prices. Without correlating results, humankind would have stopped producing long ago. Fund A's returns appear healthy, and its variability could be explained by seasonality, temporary changes in the marketplace, or randomness. Fund C's returns could also be random. However, knowing that the executives and employees of the companies in that fund are making every effort to grow earnings, the declining rate of returns is troubling. Despite their best intentions, it appears that they are failing to grow returns consistently. It is not unsound reasoning to reject Fund C, especially since funds with more favorable growth trends are available. Fund B appears to be most healthy. The efforts of its participants are succeeding in moving rates of return higher. Thus, in light of the possibility of a random walk, Brownian motion of returns, Fund B has the favorable characteristic of successful growth, and should be selected.
In any case, the increasing rate of return manifests itself as variance in the Sharpe Ratio, and variance is a proxy for risk in the Markowitz mean-variance paradigm. This flavor of variability should be considered less risky, not more so. Accounting for second-order, rates of change of returns, is beyond the scope of this paper, reserved for a future follow-up. The purpose of showing this comparison is to highlight how funds of different characteristics can have identical average and standard deviation of returns.
Let's consider another set:
We could show many more examples of where the standard deviation of sub-periodic returns is a poor proxy for risk, but let's continue...
1) Use a more accurate description of historic returns than the simple arithmetic mean (the numerator).
2) Find a more helpful characterization of risk than the standard deviation of past periodic returns (the denominator).
$P_e$
$P_b$
- the price at the end of the period
- the price at the beginning of the period.
$P_i$
$R_x$
- initial Price
- Return for each sub-period.
$P_i$
$R_n$
$n$
- initial Price
- Rate of Return for each sub-period.
- number of sub-periods
$P_i$
$R$
- initial Price
- Return for the period.
To sum logarithmic returns over several periods:
So, an improved numerator would be the average (arithmetic mean) of logarithmic returns:
This gives us a good weighting of the total compounded return for the period.
$R↖{-}$
$T_{ann}$
- average sub-periodic logarithmic return
- Number of sub-periods in one year. (monthly=12, weekly ≈ 52, daily ≈ 252)
Substituting logarithmic returns for simple arithmetic returns is an effective, easy-to-implement solution to the problems described in the numerator. This normalized return should be far more helpful to an investor than an average, sub-periodic, arithmetic return. Our improved numerator is this normalized total return, computed by adding the sub-periodic logarithmic returns, and converting to an annualized return.
Consider this fund:
In this case, the benchmark for zero-variability is simply the same fund, had it remained at its average logarithmic rate of return for each period. This is an important characteristic as we move to solve the issues with the Ratio's denominator.
But, notice we are discussing variability in Price, not variability in Returns. This is an important distinction. The standard deviation of returns does not always properly measure the variability of price, which is our goal.
Why measure variability of price and not returns? Consider these funds:
So, is the answer to simply substitute the standard deviation of price for the standard deviation of returns? Not so fast.
First, it is not the standard deviation of nominal prices that we seek to measure. A high growth fund will, by definition, have a high variability of price, while the only fund with zero variance will be a fund with zero return. What we must measure is the variability of the fund's price compared to the ideal: a fund with zero variability. Fortunately, by measuring the fund's logarithmic returns, we already have a zero-variability baseline for comparison: the same fund's periodic prices, had it earned it average logarithmic return during each sub-period, as discussed above. An elegant solution obviates the need for a separate benchmark fund, and uses its own zero-variability ideal as the benchmark, as shown here:
$P_i$
$R↖{-}$
$n$
- initial Price
- average logarithmic return
- number of sub-periods to this point
The differential we want to measure is $P_n - P_n'$. But, so that we can compare funds at varying asset prices, we normalize this price differential to a ratio of the zero-variability price: $(P_n - P_n')/P_n'$, as follows
or
$D_t ≡ P_n / {P_i e ^{R↖{-}n}} - 1$
$P_n$
$P_i$
$R↖{-}$
$n$
- actual Price at end of sub-period
- initial Price
- average logarithmic return
- number of sub-periods to this point
So, we can calculate the standard deviation of this differential ($σ_D$) over the entire period, as follows:
This standard deviation of price differentials provides more information than the standard deviation of arithmetic returns, especially if one uses variability as a proxy for risk. How far the price deviates from the ideal is far more important than a single sub-period's return.
Another advantage of this method is consistency across sub-periods of different length. When measuring the standard deviation of returns, the numbers are much smaller in shorter time periods than in longer. For example, the standard deviation of a fund using monthly returns will be many times higher than the standard deviation of daily returns. By measuring the standard deviation of price differentials, the difference in nominal prices for a day is similar in scale to the monthly or yearly price. Thus, the standard deviation numbers are more relatable, and less dependent on the time granularity chosen.
We now have a more valuable gauge of variability vis-a-vis risk. But, we still have one problem:
The following chart demonstrates how changes in the Standard Deviation of returns, in the denominator, affects the Sharpe Ratio.
for: $0 \;≦ \;σ_P \;≦ \;σ_{max}$
$R_{norm}$
$σ_P$
$σ_{max}$
$τ$
- normalized return (avg log return, normalized to simple annualized return)
- standard deviation of price differentials
- maximum acceptable $σ_P$ (investor limit)
- rate at which weighting falls with increasing variability (investor tolerance)
If we choose the maximum acceptable Standard Deviation of price differentials ($σ_{max}$) and the exponent ($τ$), we can select a preferred weighting curve:
Now our measure, which we have dubbed the "Variability-Weighted Return", is the normalized logarithmic return times a multiplier, ranging from $0$ to $1$, that weights the fund's return by a factor corresponding to the investor's preference for price variability tolerance ($τ$). This new measure contains far more information than the Sharpe Ratio.
Based on our observations, the curve representing typical investor preference for variability is similar to the curve in this chart with the exponent ($τ$) between 2 and 3. Risk averse investors, such as those near or in retirement, may wish to choose a lower $σ_{max}$ and/or a risk tolerance ($τ$) of less than one.
|
Fund
(2010-2013)
|
S&P 500 | QQQ | GLD | Pharma Fund | ||||
| $R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ | |
| Daily | 13.47 | 0.0514 | 19.02 | 0.0519 | 1.99 | 0.1704 | 20.74 | 0.0472 |
| Weekly | 13.40 | 0.0515 | 18.92 | 0.0527 | 1.98 | 0.1719 | 20.63 | 0.0473 |
| Monthly | 13.47 | 0.0513 | 19.02 | 0.0539 | 1.99 | 0.1721 | 20.74 | 0.0471 |
The first thing you may notice is that, unlike the values used in the Sharpe Ratio, the parameters we use are consistent for each fund, across daily, weekly, or monthly granularity. Properly normalized returns would be identical for each sub-period length. However, in our case, we used $52$ as the number of weeks per year, when, in our sample, we had $52.25$ weeks per year ($209$ sub-periods to cover all 4 years, with weekly closes). We used $251.5$ trading days per year, which was correct during these 4 years.
Before we continue, let's take a closer look at the 4 funds above, in relation to their zero-variability baselines, so their price variabilities become more obvious:
|
Fund
(2010-2013)
$σ_{max}$ = 0.19, $τ$ = 2
|
S&P 500 | QQQ | GLD | Pharma Fund | ||||||||||||||||
| Daily |
|
|
|
|
||||||||||||||||
| Weekly |
|
|
|
|
||||||||||||||||
| Monthly |
|
|
|
|
Which values are more meaningful? When a person tells us that a fund has a Sharpe Ratio of 0.0159, what does that tell us? First, we must ask what was used for the benchmark in the calculations. Then, we must ask about the granularity used. Did they use daily values? Weekly? Monthly? Yearly? Even then, what does 0.0159 mean? With the Variability Weighted Return (VWR), we at least can relate the value to an annual return rate, attenuated for variability. In the case of the funds above, the Sharpe Ratio did put the funds in our order of preference, but what if we change our preferences, or the funds we are considering have a greater disparity of variability?
Notes: GLD has poor returns over this period, as well as the highest variability in the group. So, it rightfully scores at the lowest value. Since its $σ_P$ is very close to the $σ_{max}$ we have chosen, it will score close to zero, regardless of return. The pharmaceutical fund has the highest return and, remarkably, the lowest $σ_P$ over this period. So, it is properly scored at the highest of the set. But, what if our preferences change? Here is an interactive tool to use to experiment with $σ_{max}$ and $τ$ values, to see how the affect the scoring:
Below, we show an example where the Sharpe Ratio fails in properly scoring the funds. Consider the following funds, in a weekly chart from 2010-2013:
We find the Sharpe Ratio values completely unhelpful here. Practically no discrimination is made between the low-return, low-volatility fund MFLDX, and the high-return, high-volatility fund SSO, even though these funds have wildly different characteristics. This is one of the problems inherent in using a ratio. Using the Sharpe Ratio, little discrimination is made between SPY and its 2x ETF cousin, SSO. Because of its extremely low volatility (See: Standard Deviation ($σ$) does not belong in the denominator, above), the short-term bond fund OSTIX has a Sharpe Ratio of more than double the next closest fund, while few investors would have preferred this fund over this period of time. Using the VWR, the scores fall in line with expectations, and one can adjust the preferences to penalize more heavily the volatility of SSO and SPY. No such adjustments are available with Sharpe.
Let's take a closer look, so we can understand why the Sharpe Ratio is nearly identical for SSO and MFLDX:
|
Fund
(2010-2013)
|
SPY | SSO | MFLDX | OSTIX | ||||
|
VWR Parameters |
$R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ |
| 15.82 | 0.05149 | 28.77 | 0.10222 | 12.00 | 0.03622 | 7.29 | 0.01286 | |
|
Sharpe Parameters |
$R↖{-}$ | $σ_D$ | $R↖{-}$ | $σ_D$ | $R↖{-}$ | $σ_D$ | $R↖{-}$ | $σ_D$ |
| 0.00252 | 0.02190 | 0.00529 | 0.04394 | 0.00175 | 0.01449 | 0.00082 | 0.00322 | |
As you can see, SSO had an $R↖{-}$ which was 3.02 times that of MFLDX. But, it also had a $σ_D$ which was 3.03 times that of MFLDX. Thus, their Sharpe Ratios are nearly identical. We find the inability of the Sharpe ratio to distinguish between these 2 vastly different funds troubling, as this could lead investors to make choices which do not well serve their portfolios. $R↖{-}$ for OSTIX approached zero during this period. But, its Sharpe denominator $σ_D$ also approached zero, launching its Sharpe Ratio to the highest of the group. Across this group of funds, the Sharpe Ratio has mislead the investor into incorrect scoring. The VWR allows investors to choose weighting preferences for returns versus variability, which can more accurately target their desired performance.
OK, one last chart. Let's take a look at the same funds, over a period which contains a market correction, to see how the indicators perform under more difficult conditions. Here are the same four funds, from 2008-2013:
Again, the VWR does a much better job of scoring these funds than does the Sharpe Ratio. Note that, because its $σ_P$ value, at 0.19107, was higher than the limit set in our preferences, SSO scored a zero using the VWR method. Using Sharpe, SSO and SPY were virtually indistinguishable, and OSTIX still scores higher than the best fund of the group.
HINT: If you wish to consider funds with the variability of SSO, change the $σ_{max}$ value in the utility above to 0.2 or higher. Then, adjust the $τ$ value to change your preference for variability weighting. As you will see, VWR scores these funds in a much more valuable manner. Here are the $R_{norm}$ and $σ_P$ values for your review:
|
Fund
(2008-2013)
|
SPY | SSO | MFLDX | OSTIX | ||||
|
VWR Parameters |
$R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ | $R_{norm}$ | $σ_P$ |
| 6.83 | 0.11375 | 5.67 | 0.19107 | 10.29 | 0.06618 | 5.93 | 0.04334 | |
|
Sharpe Parameters |
$R↖{-}$ | $σ_D$ | $R↖{-}$ | $σ_D$ | $R↖{-}$ | $σ_D$ | $R↖{-}$ | $σ_D$ |
| 0.00121 | 0.03048 | 0.00235 | 0.05970 | 0.00156 | 0.02030 | 0.00059 | 0.00492 | |
for: $0 \;≦ \;σ_P \;≦ \;σ_{max}$
$R_{norm}$
$σ_P$
$σ_{max}$
$τ$
- normalized return (avg log return, normalized to simple annualized return)
- standard deviation of price differentials
- maximum acceptable $σ_P$ (investor limit)
- rate at which weighting falls with increasing variability (investor tolerance)
What is proposed here is a more practical method of scoring funds, based on actual compounded returns and weighting for price variability. It overcomes some of the fundamental problems inherent in the Sharpe Ratio. Our new method, Variability-Weighted Return (VWR) provides the following improvements:
- Weighting for returns is now representative of actual compounded returns.
- Weighting for variability in price is a better proxy for risk than variability in sub-periodic returns.
- Weighting for variability now matches observed investor behavior vis-a-vis price variability as risk.
- Weighting for variability can now be customized per investor preferences.
- Comparison to a benchmark fund is not required.
- Scoring is less dependent upon granularity of samples (time per sub-period), and more easily comparable to others.
For more aggressive stock traders who want stock symbols rather than a single score, pair this framework with our Stocks To Watch
We would love to hear your comments. Email Us
Frequently asked questions
What is this page about?
It explains fundamental problems CrystalBull sees in Modern Portfolio Theory’s use of the Sharpe Ratio and introduces the Variability-Weighted Return (VWR) as a practical alternative scoring method using log returns and price-variability weighting.
Why prefer log returns in the numerator?
Periodic percentage returns are not additive; arithmetic means can label very different compounded outcomes as “the same.” Logarithmic returns are additive across sub-periods and map cleanly to total compounded growth, which CrystalBull then normalizes to a familiar annualized return figure.
How is VWR different from the Sharpe Ratio?
Sharpe divides average differential returns by the standard deviation of those returns. VWR multiplies a normalized log return by a variability weight between 0 and 1 based on how far prices wander from a constant-log-growth path, with investor-chosen limits (σ_max) and tolerance (τ)—avoiding infinite scores when volatility approaches zero.
Who is this for?
Investors, advisors, and researchers comparing funds or strategies on return versus variability—especially anyone who finds Sharpe rankings unintuitive across high-vol growers and low-vol low-return vehicles. CrystalBull also ties the motivation to how it thinks about return-versus-variability in its live timing stack.
What are the limitations?
VWR still relies on historical sample paths and user-chosen parameters (σ_max, τ); different choices change rankings. It does not remove market risk or forecast future returns. The article is educational methodology, not a certified performance composite or a trade signal.